3
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

3
U.S. (TOLL FREE)
+1 (315) 215-3225
Sickle Cell Anemia Testing & Screening - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-31C5597
Home | Market Reports | Health| Health Conditions| Genetic Disorders
Global Sickle Cell Anemia Testing Screening Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Sickle Cell Anemia Testing & Screening - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-31C5597
Report
October 2024
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Sickle Cell Anemia Testing & Screening - Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Sickle Cell Anemia Testing & Screening - Market

Sickle Cell Anemia Testing & Screening - Market

Sickle Cell Disease, an inherited blood disorder, often causes red blood cells (RBCs) to become sickle-shaped through the presence of the abnormal hemoglobin S variant. Highly rigid sickle-shaped blood may have difficulty passing through small blood vessels, blocking the normal blood flow, damaging tissues, and ultimately leading to many of the complications of Sickle Cell Disease.
The global market for Sickle Cell Anemia Testing & Screening was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Sickle Cell Anemia Testing & Screening, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Sickle Cell Anemia Testing & Screening by region & country, by Type, and by Application.
The Sickle Cell Anemia Testing & Screening market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sickle Cell Anemia Testing & Screening.
Market Segmentation

Scope of Sickle Cell Anemia Testing & Screening - Market Report

Report Metric Details
Report Name Sickle Cell Anemia Testing & Screening - Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type:
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company STRECK, INC., BioMedomics Inc., Laboratory Corporation of America Holdings, Silver Lake Research Corporation, HEMEX HEALTH, Bio-Rad Laboratories, Inc., PerkinElmer Inc., Quest Diagnostics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Sickle Cell Anemia Testing & Screening manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Sickle Cell Anemia Testing & Screening in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Sickle Cell Anemia Testing & Screening in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Sickle Cell Anemia Testing & Screening - Market report?

Ans: The main players in the Sickle Cell Anemia Testing & Screening - Market are STRECK, INC., BioMedomics Inc., Laboratory Corporation of America Holdings, Silver Lake Research Corporation, HEMEX HEALTH, Bio-Rad Laboratories, Inc., PerkinElmer Inc., Quest Diagnostics

What are the Application segmentation covered in the Sickle Cell Anemia Testing & Screening - Market report?

Ans: The Applications covered in the Sickle Cell Anemia Testing & Screening - Market report are Newborn Screening (12 months and below), Adult Screening (25 to 60 years), Other Age Groups (1 to 25 & above 60 years)

What are the Type segmentation covered in the Sickle Cell Anemia Testing & Screening - Market report?

Ans: The Types covered in the Sickle Cell Anemia Testing & Screening - Market report are Hemoglobin Electrophoresis, High-performance Liquid Chromatography (HPLC), Point-of-Care Tests, Other Tests

Recommended Reports

Blood Testing Devices

Hemoglobin Analytics

Blood Disease Diagnostics

1 Market Overview
1.1 Sickle Cell Anemia Testing & Screening Product Introduction
1.2 Global Sickle Cell Anemia Testing & Screening Market Size Forecast
1.3 Sickle Cell Anemia Testing & Screening Market Trends & Drivers
1.3.1 Sickle Cell Anemia Testing & Screening Industry Trends
1.3.2 Sickle Cell Anemia Testing & Screening Market Drivers & Opportunity
1.3.3 Sickle Cell Anemia Testing & Screening Market Challenges
1.3.4 Sickle Cell Anemia Testing & Screening Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Sickle Cell Anemia Testing & Screening Players Revenue Ranking (2023)
2.2 Global Sickle Cell Anemia Testing & Screening Revenue by Company (2019-2024)
2.3 Key Companies Sickle Cell Anemia Testing & Screening Manufacturing Base Distribution and Headquarters
2.4 Key Companies Sickle Cell Anemia Testing & Screening Product Offered
2.5 Key Companies Time to Begin Mass Production of Sickle Cell Anemia Testing & Screening
2.6 Sickle Cell Anemia Testing & Screening Market Competitive Analysis
2.6.1 Sickle Cell Anemia Testing & Screening Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Sickle Cell Anemia Testing & Screening Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sickle Cell Anemia Testing & Screening as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Hemoglobin Electrophoresis
3.1.2 High-performance Liquid Chromatography (HPLC)
3.1.3 Point-of-Care Tests
3.1.4 Other Tests
3.2 Global Sickle Cell Anemia Testing & Screening Sales Value by Type
3.2.1 Global Sickle Cell Anemia Testing & Screening Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Sickle Cell Anemia Testing & Screening Sales Value, by Type (2019-2030)
3.2.3 Global Sickle Cell Anemia Testing & Screening Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Newborn Screening (12 months and below)
4.1.2 Adult Screening (25 to 60 years)
4.1.3 Other Age Groups (1 to 25 & above 60 years)
4.2 Global Sickle Cell Anemia Testing & Screening Sales Value by Application
4.2.1 Global Sickle Cell Anemia Testing & Screening Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Sickle Cell Anemia Testing & Screening Sales Value, by Application (2019-2030)
4.2.3 Global Sickle Cell Anemia Testing & Screening Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Sickle Cell Anemia Testing & Screening Sales Value by Region
5.1.1 Global Sickle Cell Anemia Testing & Screening Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Sickle Cell Anemia Testing & Screening Sales Value by Region (2019-2024)
5.1.3 Global Sickle Cell Anemia Testing & Screening Sales Value by Region (2025-2030)
5.1.4 Global Sickle Cell Anemia Testing & Screening Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Sickle Cell Anemia Testing & Screening Sales Value, 2019-2030
5.2.2 North America Sickle Cell Anemia Testing & Screening Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Sickle Cell Anemia Testing & Screening Sales Value, 2019-2030
5.3.2 Europe Sickle Cell Anemia Testing & Screening Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Sickle Cell Anemia Testing & Screening Sales Value, 2019-2030
5.4.2 Asia Pacific Sickle Cell Anemia Testing & Screening Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Sickle Cell Anemia Testing & Screening Sales Value, 2019-2030
5.5.2 South America Sickle Cell Anemia Testing & Screening Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Sickle Cell Anemia Testing & Screening Sales Value, 2019-2030
5.6.2 Middle East & Africa Sickle Cell Anemia Testing & Screening Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Sickle Cell Anemia Testing & Screening Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Sickle Cell Anemia Testing & Screening Sales Value
6.3 United States
6.3.1 United States Sickle Cell Anemia Testing & Screening Sales Value, 2019-2030
6.3.2 United States Sickle Cell Anemia Testing & Screening Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Sickle Cell Anemia Testing & Screening Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Sickle Cell Anemia Testing & Screening Sales Value, 2019-2030
6.4.2 Europe Sickle Cell Anemia Testing & Screening Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Sickle Cell Anemia Testing & Screening Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Sickle Cell Anemia Testing & Screening Sales Value, 2019-2030
6.5.2 China Sickle Cell Anemia Testing & Screening Sales Value by Type (%), 2023 VS 2030
6.5.3 China Sickle Cell Anemia Testing & Screening Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Sickle Cell Anemia Testing & Screening Sales Value, 2019-2030
6.6.2 Japan Sickle Cell Anemia Testing & Screening Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Sickle Cell Anemia Testing & Screening Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Sickle Cell Anemia Testing & Screening Sales Value, 2019-2030
6.7.2 South Korea Sickle Cell Anemia Testing & Screening Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Sickle Cell Anemia Testing & Screening Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Sickle Cell Anemia Testing & Screening Sales Value, 2019-2030
6.8.2 Southeast Asia Sickle Cell Anemia Testing & Screening Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Sickle Cell Anemia Testing & Screening Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Sickle Cell Anemia Testing & Screening Sales Value, 2019-2030
6.9.2 India Sickle Cell Anemia Testing & Screening Sales Value by Type (%), 2023 VS 2030
6.9.3 India Sickle Cell Anemia Testing & Screening Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 STRECK, INC.
7.1.1 STRECK, INC. Profile
7.1.2 STRECK, INC. Main Business
7.1.3 STRECK, INC. Sickle Cell Anemia Testing & Screening Products, Services and Solutions
7.1.4 STRECK, INC. Sickle Cell Anemia Testing & Screening Revenue (US$ Million) & (2019-2024)
7.1.5 STRECK, INC. Recent Developments
7.2 BioMedomics Inc.
7.2.1 BioMedomics Inc. Profile
7.2.2 BioMedomics Inc. Main Business
7.2.3 BioMedomics Inc. Sickle Cell Anemia Testing & Screening Products, Services and Solutions
7.2.4 BioMedomics Inc. Sickle Cell Anemia Testing & Screening Revenue (US$ Million) & (2019-2024)
7.2.5 BioMedomics Inc. Recent Developments
7.3 Laboratory Corporation of America Holdings
7.3.1 Laboratory Corporation of America Holdings Profile
7.3.2 Laboratory Corporation of America Holdings Main Business
7.3.3 Laboratory Corporation of America Holdings Sickle Cell Anemia Testing & Screening Products, Services and Solutions
7.3.4 Laboratory Corporation of America Holdings Sickle Cell Anemia Testing & Screening Revenue (US$ Million) & (2019-2024)
7.3.5 Silver Lake Research Corporation Recent Developments
7.4 Silver Lake Research Corporation
7.4.1 Silver Lake Research Corporation Profile
7.4.2 Silver Lake Research Corporation Main Business
7.4.3 Silver Lake Research Corporation Sickle Cell Anemia Testing & Screening Products, Services and Solutions
7.4.4 Silver Lake Research Corporation Sickle Cell Anemia Testing & Screening Revenue (US$ Million) & (2019-2024)
7.4.5 Silver Lake Research Corporation Recent Developments
7.5 HEMEX HEALTH
7.5.1 HEMEX HEALTH Profile
7.5.2 HEMEX HEALTH Main Business
7.5.3 HEMEX HEALTH Sickle Cell Anemia Testing & Screening Products, Services and Solutions
7.5.4 HEMEX HEALTH Sickle Cell Anemia Testing & Screening Revenue (US$ Million) & (2019-2024)
7.5.5 HEMEX HEALTH Recent Developments
7.6 Bio-Rad Laboratories, Inc.
7.6.1 Bio-Rad Laboratories, Inc. Profile
7.6.2 Bio-Rad Laboratories, Inc. Main Business
7.6.3 Bio-Rad Laboratories, Inc. Sickle Cell Anemia Testing & Screening Products, Services and Solutions
7.6.4 Bio-Rad Laboratories, Inc. Sickle Cell Anemia Testing & Screening Revenue (US$ Million) & (2019-2024)
7.6.5 Bio-Rad Laboratories, Inc. Recent Developments
7.7 PerkinElmer Inc.
7.7.1 PerkinElmer Inc. Profile
7.7.2 PerkinElmer Inc. Main Business
7.7.3 PerkinElmer Inc. Sickle Cell Anemia Testing & Screening Products, Services and Solutions
7.7.4 PerkinElmer Inc. Sickle Cell Anemia Testing & Screening Revenue (US$ Million) & (2019-2024)
7.7.5 PerkinElmer Inc. Recent Developments
7.8 Quest Diagnostics
7.8.1 Quest Diagnostics Profile
7.8.2 Quest Diagnostics Main Business
7.8.3 Quest Diagnostics Sickle Cell Anemia Testing & Screening Products, Services and Solutions
7.8.4 Quest Diagnostics Sickle Cell Anemia Testing & Screening Revenue (US$ Million) & (2019-2024)
7.8.5 Quest Diagnostics Recent Developments
8 Industry Chain Analysis
8.1 Sickle Cell Anemia Testing & Screening Industrial Chain
8.2 Sickle Cell Anemia Testing & Screening Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Sickle Cell Anemia Testing & Screening Sales Model
8.5.2 Sales Channel
8.5.3 Sickle Cell Anemia Testing & Screening Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Sickle Cell Anemia Testing & Screening Market Trends
    Table 2. Sickle Cell Anemia Testing & Screening Market Drivers & Opportunity
    Table 3. Sickle Cell Anemia Testing & Screening Market Challenges
    Table 4. Sickle Cell Anemia Testing & Screening Market Restraints
    Table 5. Global Sickle Cell Anemia Testing & Screening Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Sickle Cell Anemia Testing & Screening Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Sickle Cell Anemia Testing & Screening Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Sickle Cell Anemia Testing & Screening Product Type
    Table 9. Key Companies Time to Begin Mass Production of Sickle Cell Anemia Testing & Screening
    Table 10. Global Sickle Cell Anemia Testing & Screening Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sickle Cell Anemia Testing & Screening as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Sickle Cell Anemia Testing & Screening Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Sickle Cell Anemia Testing & Screening Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Sickle Cell Anemia Testing & Screening Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Sickle Cell Anemia Testing & Screening Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Sickle Cell Anemia Testing & Screening Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Sickle Cell Anemia Testing & Screening Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Sickle Cell Anemia Testing & Screening Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Sickle Cell Anemia Testing & Screening Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Sickle Cell Anemia Testing & Screening Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Sickle Cell Anemia Testing & Screening Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Sickle Cell Anemia Testing & Screening Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Sickle Cell Anemia Testing & Screening Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Sickle Cell Anemia Testing & Screening Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Sickle Cell Anemia Testing & Screening Sales Value by Region (2019-2024) & (%)
    Table 27. Global Sickle Cell Anemia Testing & Screening Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Sickle Cell Anemia Testing & Screening Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Sickle Cell Anemia Testing & Screening Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Sickle Cell Anemia Testing & Screening Sales Value, (2025-2030) & (US$ Million)
    Table 31. STRECK, INC. Basic Information List
    Table 32. STRECK, INC. Description and Business Overview
    Table 33. STRECK, INC. Sickle Cell Anemia Testing & Screening Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Sickle Cell Anemia Testing & Screening Business of STRECK, INC. (2019-2024)
    Table 35. STRECK, INC. Recent Developments
    Table 36. BioMedomics Inc. Basic Information List
    Table 37. BioMedomics Inc. Description and Business Overview
    Table 38. BioMedomics Inc. Sickle Cell Anemia Testing & Screening Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Sickle Cell Anemia Testing & Screening Business of BioMedomics Inc. (2019-2024)
    Table 40. BioMedomics Inc. Recent Developments
    Table 41. Laboratory Corporation of America Holdings Basic Information List
    Table 42. Laboratory Corporation of America Holdings Description and Business Overview
    Table 43. Laboratory Corporation of America Holdings Sickle Cell Anemia Testing & Screening Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Sickle Cell Anemia Testing & Screening Business of Laboratory Corporation of America Holdings (2019-2024)
    Table 45. Laboratory Corporation of America Holdings Recent Developments
    Table 46. Silver Lake Research Corporation Basic Information List
    Table 47. Silver Lake Research Corporation Description and Business Overview
    Table 48. Silver Lake Research Corporation Sickle Cell Anemia Testing & Screening Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Sickle Cell Anemia Testing & Screening Business of Silver Lake Research Corporation (2019-2024)
    Table 50. Silver Lake Research Corporation Recent Developments
    Table 51. HEMEX HEALTH Basic Information List
    Table 52. HEMEX HEALTH Description and Business Overview
    Table 53. HEMEX HEALTH Sickle Cell Anemia Testing & Screening Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Sickle Cell Anemia Testing & Screening Business of HEMEX HEALTH (2019-2024)
    Table 55. HEMEX HEALTH Recent Developments
    Table 56. Bio-Rad Laboratories, Inc. Basic Information List
    Table 57. Bio-Rad Laboratories, Inc. Description and Business Overview
    Table 58. Bio-Rad Laboratories, Inc. Sickle Cell Anemia Testing & Screening Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Sickle Cell Anemia Testing & Screening Business of Bio-Rad Laboratories, Inc. (2019-2024)
    Table 60. Bio-Rad Laboratories, Inc. Recent Developments
    Table 61. PerkinElmer Inc. Basic Information List
    Table 62. PerkinElmer Inc. Description and Business Overview
    Table 63. PerkinElmer Inc. Sickle Cell Anemia Testing & Screening Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Sickle Cell Anemia Testing & Screening Business of PerkinElmer Inc. (2019-2024)
    Table 65. PerkinElmer Inc. Recent Developments
    Table 66. Quest Diagnostics Basic Information List
    Table 67. Quest Diagnostics Description and Business Overview
    Table 68. Quest Diagnostics Sickle Cell Anemia Testing & Screening Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Sickle Cell Anemia Testing & Screening Business of Quest Diagnostics (2019-2024)
    Table 70. Quest Diagnostics Recent Developments
    Table 71. Key Raw Materials Lists
    Table 72. Raw Materials Key Suppliers Lists
    Table 73. Sickle Cell Anemia Testing & Screening Downstream Customers
    Table 74. Sickle Cell Anemia Testing & Screening Distributors List
    Table 75. Research Programs/Design for This Report
    Table 76. Key Data Information from Secondary Sources
    Table 77. Key Data Information from Primary Sources
    Table 78. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Sickle Cell Anemia Testing & Screening Product Picture
    Figure 2. Global Sickle Cell Anemia Testing & Screening Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Sickle Cell Anemia Testing & Screening Sales Value (2019-2030) & (US$ Million)
    Figure 4. Sickle Cell Anemia Testing & Screening Report Years Considered
    Figure 5. Global Sickle Cell Anemia Testing & Screening Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Sickle Cell Anemia Testing & Screening Revenue in 2023
    Figure 7. Sickle Cell Anemia Testing & Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Hemoglobin Electrophoresis Picture
    Figure 9. High-performance Liquid Chromatography (HPLC) Picture
    Figure 10. Point-of-Care Tests Picture
    Figure 11. Other Tests Picture
    Figure 12. Global Sickle Cell Anemia Testing & Screening Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 13. Global Sickle Cell Anemia Testing & Screening Sales Value Market Share by Type, 2023 & 2030
    Figure 14. Product Picture of Newborn Screening (12 months and below)
    Figure 15. Product Picture of Adult Screening (25 to 60 years)
    Figure 16. Product Picture of Other Age Groups (1 to 25 & above 60 years)
    Figure 17. Global Sickle Cell Anemia Testing & Screening Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 18. Global Sickle Cell Anemia Testing & Screening Sales Value Market Share by Application, 2023 & 2030
    Figure 19. North America Sickle Cell Anemia Testing & Screening Sales Value (2019-2030) & (US$ Million)
    Figure 20. North America Sickle Cell Anemia Testing & Screening Sales Value by Country (%), 2023 VS 2030
    Figure 21. Europe Sickle Cell Anemia Testing & Screening Sales Value (2019-2030) & (US$ Million)
    Figure 22. Europe Sickle Cell Anemia Testing & Screening Sales Value by Country (%), 2023 VS 2030
    Figure 23. Asia Pacific Sickle Cell Anemia Testing & Screening Sales Value (2019-2030) & (US$ Million)
    Figure 24. Asia Pacific Sickle Cell Anemia Testing & Screening Sales Value by Country (%), 2023 VS 2030
    Figure 25. South America Sickle Cell Anemia Testing & Screening Sales Value (2019-2030) & (US$ Million)
    Figure 26. South America Sickle Cell Anemia Testing & Screening Sales Value by Country (%), 2023 VS 2030
    Figure 27. Middle East & Africa Sickle Cell Anemia Testing & Screening Sales Value (2019-2030) & (US$ Million)
    Figure 28. Middle East & Africa Sickle Cell Anemia Testing & Screening Sales Value by Country (%), 2023 VS 2030
    Figure 29. Key Countries/Regions Sickle Cell Anemia Testing & Screening Sales Value (%), (2019-2030)
    Figure 30. United States Sickle Cell Anemia Testing & Screening Sales Value, (2019-2030) & (US$ Million)
    Figure 31. United States Sickle Cell Anemia Testing & Screening Sales Value by Type (%), 2023 VS 2030
    Figure 32. United States Sickle Cell Anemia Testing & Screening Sales Value by Application (%), 2023 VS 2030
    Figure 33. Europe Sickle Cell Anemia Testing & Screening Sales Value, (2019-2030) & (US$ Million)
    Figure 34. Europe Sickle Cell Anemia Testing & Screening Sales Value by Type (%), 2023 VS 2030
    Figure 35. Europe Sickle Cell Anemia Testing & Screening Sales Value by Application (%), 2023 VS 2030
    Figure 36. China Sickle Cell Anemia Testing & Screening Sales Value, (2019-2030) & (US$ Million)
    Figure 37. China Sickle Cell Anemia Testing & Screening Sales Value by Type (%), 2023 VS 2030
    Figure 38. China Sickle Cell Anemia Testing & Screening Sales Value by Application (%), 2023 VS 2030
    Figure 39. Japan Sickle Cell Anemia Testing & Screening Sales Value, (2019-2030) & (US$ Million)
    Figure 40. Japan Sickle Cell Anemia Testing & Screening Sales Value by Type (%), 2023 VS 2030
    Figure 41. Japan Sickle Cell Anemia Testing & Screening Sales Value by Application (%), 2023 VS 2030
    Figure 42. South Korea Sickle Cell Anemia Testing & Screening Sales Value, (2019-2030) & (US$ Million)
    Figure 43. South Korea Sickle Cell Anemia Testing & Screening Sales Value by Type (%), 2023 VS 2030
    Figure 44. South Korea Sickle Cell Anemia Testing & Screening Sales Value by Application (%), 2023 VS 2030
    Figure 45. Southeast Asia Sickle Cell Anemia Testing & Screening Sales Value, (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Sickle Cell Anemia Testing & Screening Sales Value by Type (%), 2023 VS 2030
    Figure 47. Southeast Asia Sickle Cell Anemia Testing & Screening Sales Value by Application (%), 2023 VS 2030
    Figure 48. India Sickle Cell Anemia Testing & Screening Sales Value, (2019-2030) & (US$ Million)
    Figure 49. India Sickle Cell Anemia Testing & Screening Sales Value by Type (%), 2023 VS 2030
    Figure 50. India Sickle Cell Anemia Testing & Screening Sales Value by Application (%), 2023 VS 2030
    Figure 51. Sickle Cell Anemia Testing & Screening Industrial Chain
    Figure 52. Sickle Cell Anemia Testing & Screening Manufacturing Cost Structure
    Figure 53. Channels of Distribution (Direct Sales, and Distribution)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

RELATED REPORTS

Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24R5886
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Lysosomal Storage Diseases Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34Q5936
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Acute Intermittent Porphyria Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6U7336
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Phenylketonuria Treatment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12R6229
Mon Sep 08 00:00:00 UTC 2025

Add to Cart